A randomized, open-label, single-dose, pilot study to evaluate the safety and efficacy of OROS hydromorphone in patients with acute, moderate-to-severe postoperative pain.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2009
At a glance
- Drugs Hydromorphone (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 21 Jul 2009 Actual patient number (50) added as reported by ClinicalTrials.gov.
- 08 Jan 2007 New trial record.